Your Account
close button

Use our patient tools for secure, convenient, 24/7 access. Learn more

OR

This facility is a member of


Connect with us:

Kidney Cancer

   

A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE)0005 (VEGF Trap) in Patients with Metastatic Renal Cell Carcinoma [ECOG 4805]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

 

Share